This blog discusses some of the challenges of value assessment frameworks, specifically those developed by the Institute for Clinical and Economic Review (ICER). Hear from the National Pharmaceutical Council (NPC), PhRMA, and the Academy of Managed Care Pharmacy (AMCP) on particular concerns they have, including real-world evidence, budget impact, Economic model transparency and QALY.
This blog also looks into how these concerns can be visually presented using a new methodology called PepperSlice.
Read more here. (Source: Tracy Allison Altman and Patti Peeples, tHEORetically Speaking, 11/30/16)